Sharon v. CVS Pharmacy, Inc.

CourtDistrict Court, D. Nevada
DecidedMarch 11, 2024
Docket2:22-cv-00453
StatusUnknown

This text of Sharon v. CVS Pharmacy, Inc. (Sharon v. CVS Pharmacy, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sharon v. CVS Pharmacy, Inc., (D. Nev. 2024).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 DISTRICT OF NEVADA 6 * * *

7 THOMAS A. SHARON, Case No. 2:22-cv-00453-RFB-NJK

8 Plaintiff, ORDER

9 v.

10 CVS PHARMACY, INC., et al.,

11 Defendants.

12 13 Before the Court are Defendant CVS Pharmacy, Inc.’s (“CVS”) Motion for Entry of 14 Judgement (ECF No. 54) and Motion for Summary Judgment (ECF No. 57) as well as Plaintiff’s 15 failure to prosecute this action. Because the Court dismisses the case sua sponte, it denies both 16 CVS’ Motion for Summary Judgement and Motion for Entry of Judgement as moot. 17 I. FACTUAL ALLEGATIONS1 18 Plaintiff Dr. Thomas Sharon is a licensed and board-certified advanced registered nurse 19 practitioner in Nevada. He has a CII license to prescribe medications containing controlled 20 substances. Over the two years immediately preceding the filing of the Complaint, Dr. Sharon 21 treated numerous patients with COVID-19 and similar viruses that manifest with cold and flu 22 symptoms. Dr. Sharon issued prescriptions for many of these patients. Certain of those patients 23 exhibited symptoms warranting prescriptions for cough medicine that contains Codeine and/or 24 other controlled substances. All such prescriptions were issued by Dr. Sharon in a manner 25 consistent with longstanding and well-accepted medical guidelines. Some of those prescriptions 26 27 28 1 As no Amended Complaint has been filed, for context the Court summarizes the factual allegations made in the initial Complaint (ECF No. 1) here. 1 have been filled by Dr. Sharon’s patients at CVS pharmacies in Nevada and elsewhere. 2 In September 2021, CVS contacted Dr. Sharon’s office, leaving a message indicating 3 they wished to discuss the volume of Promethazine with Codeine prescriptions that had been 4 written by Plaintiff. Dr. Sharon contacted CVS and explained the increased frequency of these 5 prescriptions were due to the increased number of COVID-19 patients. Subsequently, CVS 6 determined without any further support, that the prescription rate was too high and CVS’s 7 representatives advised Plaintiff that CVS would monitor his prescriptions. 8 Approximately 60 days later, contrary to its representation that it would simply monitor 9 Dr. Sharon’s prescriptions, and without any further communication or warning, CVS instituted a 10 company-wide block of any prescription written by Dr. Sharon containing a controlled 11 substance. Plaintiff subsequently learned that CVS informed its pharmacists in the Las Vegas 12 area that Sharon is not licensed to write prescriptions for controlled substances. 13 II. PROCEEDURAL HISTORY 14 Dr. Sharon filed a Complaint in the Nevada Eighth Judicial District Court for Clark 15 County on February 8, 2022, which was removed to this Court by CVS on March 14, 2022. ECF 16 No. 1. The Complaint alleged six causes of action: Negligence (“first cause of action”), 17 Intentional Interference with Economic Relations (“second cause of action”), Intentional 18 Interference with Prospective Economic Advantage (“third cause of action”), Civil Conspiracy 19 (“fourth cause of action”), Slander per se (labeled “seventh cause of action”), and Injunctive 20 Relief (labeled “eighth cause of action”). Id. On March 4, 2022, Defendants filed a Motion to 21 dismiss, which was fully briefed. ECF Nos. 6, 8, 10. On August 10, 2022, Plaintiff’s attorney 22 filed a Motion to Withdraw, which the Court granted on August 23, 2022. ECF Nos. 22, 27. On 23 September 22, 2022, Plaintiff filed a declaration with the Court stating his intent to proceed pro 24 se. ECF No. 28. The same day, Plaintiff consented to electronic service. ECF No. 29. 25 On September 23, 2022, this matter was reassigned to Judge Richard F. Boulware, II. 26 ECF No. 30, 31. On October 19, 2022, Defendant CVS Pharmacy, Inc. filed the instant First 27 Motion for Leave to File Document, seeking to supplement the Motion to Dismiss with authority 28 from Reiner v. CVS Pharmacy, Inc., et al., Case No. 2:22-cv-00701-RFB-EJY. ECF Nos. 39, 40. 1 Plaintiff filed a Response on November 8, 2022. ECF No. 41. 2 On March 24, 2023, the Court held a hearing regarding the pending motions. ECF No. 3 52. The Court dismissed with prejudice Plaintiff’s first cause of action for Negligence, fourth 4 cause of action for Civil Conspiracy, and fifth cause of action for injunctive relief without leave 5 to amend. Id. The Court dismissed the remaining causes of action (i.e., the second, third, and 6 seventh) without prejudice. Id. The Court ordered Plaintiff to file any amended complaint by 7 April 10, 2023. Id. 8 On May 3, 2023, CVS moved for judgement to be entered as Plaintiff failed to file an 9 amended complaint. ECF No. 54. No response was filed by Plaintiff. On May 9, 2023, CVS 10 moved for summary judgement. ECF No. 57. No response was filed by Plaintiff. 11 III. LEGAL STANDARDS 12 District courts have inherent power to control their dockets. Thompson v. Housing Auth. 13 of L.A., 782 F.2d 829, 831 (9th Cir. 1986) (per curiam). In the exercise of that power, they may 14 impose sanctions including, where appropriate, default or dismissal. Id. (citing Link v. Wabash 15 R.R. Co., 370 U.S. 626, 628 (1961). A Court may dismiss sua sponte or on the motion of a 16 Defendant under Federal Rule of Civil Procedure 41(b). Link v. Wabash R. Co., 370 U.S. 626, 17 633 (1962); Oliva v. Sullivan, 958 F.2d 272, 274 (9th Cir. 1992). Dismissal is a harsh remedy, 18 however, and should only be imposed in “extreme circumstances.” Henderson v. Duncan, 779 19 F.2d 1421, 1423 (9th Cir. 1986). 20 To determine whether to dismiss an action for failure to prosecute and failure to obey a 21 Court order, the Court must consider several factors, including: (1) the public’s interest in 22 expeditious resolution of litigation; (2) the Court’s need to manage its docket; (3) the risk of 23 prejudice to the defendants; (4) the public policy favoring disposition of cases on their merits; 24 and (5) the availability of less drastic sanctions. Ferdik v. Bonzelet, 963 F.2d 1258, 1260-61 (9th 25 Cir. 1992); Henderson, 779 F.2d at 1424. In cases of sua sponte dismissal, there is a “closer 26 focus” on the consideration of less drastic alternatives and the provision of a warning of 27 imminent dismissal. Oliva, 958 F.2d at 274. Though the lack of a warning or an adversary 28 hearing does not necessarily render dismissal void. Link, 370 U.S. at 632. 1 IV. DISCUSSION 2 The Court addresses first Plaintiff Dr. Sharon’s failure to comply with this Court’s March 3 24, 2023, instruction, before turning to Defendant CVS’ Motion for Judgement and Motion for 4 Summary Judgment. For the reasons below, the Court finds Plaintiff’s remaining claims should 5 be dismissed with prejudice and Defendant’s motions denied as moot. 6 7 A. Dismissal Under Inherent Powers While Dr. Sharon is proceeding pro se, he nevertheless bears the responsibility of 8 prosecuting this case with due diligence. The Court finds that the relevant factors counsel 9 dismissal of the action sua sponte for a failure to prosecute and a failure to obey a Court order. 10 See Hamilton Copper & Steel Corp. v. Primary Steel, Inc., 898 F.2d 1428 (9th Cir. 1990). 11 The Complaint was dismissed at the hearing held on March 24, 2023.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Sharon v. CVS Pharmacy, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/sharon-v-cvs-pharmacy-inc-nvd-2024.